2021 Q1 Form 10-K Financial Statement

#000139305221000015 Filed on March 30, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q1 2019 Q4
Revenue $396.8M $311.5M $280.9M
YoY Change 27.37% 34.08% 25.0%
Cost Of Revenue $113.8M $94.30M $73.33M
YoY Change 20.68% 46.2% 19.48%
Gross Profit $282.9M $217.2M $207.6M
YoY Change 30.26% 29.44% 27.08%
Gross Profit Margin 71.31% 69.72% 73.9%
Selling, General & Admin $102.1M $95.60M $74.22M
YoY Change 6.8% 54.19% 23.16%
% of Gross Profit 36.09% 44.02% 35.75%
Research & Development $81.90M $61.20M $52.58M
YoY Change 33.82% 42.99% 31.43%
% of Gross Profit 28.95% 28.18% 25.33%
Depreciation & Amortization $6.800M $11.20M $2.000M
YoY Change -39.29% 211.11% 33.33%
% of Gross Profit 2.4% 5.16% 0.96%
Operating Expenses $184.1M $156.8M $126.8M
YoY Change 17.41% 49.62% 26.46%
Operating Profit $98.84M $60.39M $80.80M
YoY Change 63.66% -4.13% 28.06%
Interest Expense -$700.0K
YoY Change -66.67%
% of Operating Profit -1.16%
Other Income/Expense, Net $6.400M $4.800M $9.141M
YoY Change 33.33% -15.79% 98.46%
Pretax Income $105.3M $65.20M $89.94M
YoY Change 61.5% -5.09% 32.85%
Income Tax $2.400M -$900.0K $7.696M
% Of Pretax Income 2.28% -1.38% 8.56%
Net Earnings $102.9M $66.18M $82.25M
YoY Change 55.51% -6.98% 28.34%
Net Earnings / Revenue 25.94% 21.25% 29.28%
Basic Earnings Per Share $0.68 $0.44 $0.56
Diluted Earnings Per Share $0.64 $0.42 $0.52
COMMON SHARES
Basic Shares Outstanding 148.2M shares
Diluted Shares Outstanding 158.8M shares

Balance Sheet

Concept 2021 Q1 2020 Q1 2019 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.664B $1.087B $1.495B
YoY Change 53.08% -0.31% 42.12%
Cash & Equivalents $730.5M $476.7M $892.6M
Short-Term Investments $933.1M $610.0M $602.4M
Other Short-Term Assets $35.60M $21.90M $15.40M
YoY Change 62.56% 0.92% -27.36%
Inventory
Prepaid Expenses
Receivables $564.4M $389.7M $116.9M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $2.311B $1.531B $1.658B
YoY Change 50.92% 6.82% 40.14%
LONG-TERM ASSETS
Property, Plant & Equipment $53.65M $54.75M $53.29M
YoY Change -2.01% -0.39% -0.6%
Goodwill $436.0M $438.5M $95.80M
YoY Change -0.57% 357.74%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $17.88M $16.18M $12.90M
YoY Change 10.47% 96.07% -66.51%
Total Long-Term Assets $735.2M $740.7M $242.3M
YoY Change -0.73% 236.12% 13.18%
TOTAL ASSETS
Total Short-Term Assets $2.311B $1.531B $1.658B
Total Long-Term Assets $735.2M $740.7M $242.3M
Total Assets $3.046B $2.272B $1.900B
YoY Change 34.08% 37.37% 36.01%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $23.25M $19.42M $9.914M
YoY Change 19.74% 113.17% -9.05%
Accrued Expenses $72.70M $56.20M $38.10M
YoY Change 29.36% 78.41% 43.23%
Deferred Revenue $617.0M $468.9M $250.7M
YoY Change 31.59% 31.58%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $400.0K $1.100M $1.000M
YoY Change -63.64%
Total Short-Term Liabilities $716.0M $551.2M $306.9M
YoY Change 29.9% 37.44% 29.66%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $400.0K $600.0K
YoY Change -100.0%
Other Long-Term Liabilities $10.57M $7.779M $6.055M
YoY Change 35.84% -12.6% -25.25%
Total Long-Term Liabilities $10.57M $7.779M $6.055M
YoY Change 35.84% -12.6% -25.25%
TOTAL LIABILITIES
Total Short-Term Liabilities $716.0M $551.2M $306.9M
Total Long-Term Liabilities $10.57M $7.779M $6.055M
Total Liabilities $779.7M $606.2M $341.9M
YoY Change 28.63% 45.71% 32.0%
SHAREHOLDERS EQUITY
Retained Earnings $1.300B $919.7M $853.5M
YoY Change 41.32% 48.52%
Common Stock $965.7M $745.5M $704.9M
YoY Change 29.54% 20.7%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.266B $1.666B $1.559B
YoY Change
Total Liabilities & Shareholders Equity $3.046B $2.272B $1.900B
YoY Change 34.08% 37.37% 36.01%

Cashflow Statement

Concept 2021 Q1 2020 Q1 2019 Q4
OPERATING ACTIVITIES
Net Income $102.9M $66.18M $82.25M
YoY Change 55.51% -6.98% 28.34%
Depreciation, Depletion And Amortization $6.800M $11.20M $2.000M
YoY Change -39.29% 211.11% 33.33%
Cash From Operating Activities $68.30M $39.10M $61.50M
YoY Change 74.68% 22.96% 48.0%
INVESTING ACTIVITIES
Capital Expenditures -$200.0K -$100.0K $881.0K
YoY Change 100.0% -96.88% -78.84%
Acquisitions
YoY Change
Other Investing Activities $21.30M -$455.2M $4.000M
YoY Change -104.68% -1068.51% -104.72%
Cash From Investing Activities $21.10M -$455.3M $2.729M
YoY Change -104.63% -1139.5% -103.05%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 9.000M 2.100M $1.366M
YoY Change 328.57% -66.13% -71.93%
NET CHANGE
Cash From Operating Activities 68.30M 39.10M $61.50M
Cash From Investing Activities 21.10M -455.3M $2.729M
Cash From Financing Activities 9.000M 2.100M $1.366M
Net Change In Cash 98.40M -414.1M $65.11M
YoY Change -123.76% -606.23% -247.68%
FREE CASH FLOW
Cash From Operating Activities $68.30M $39.10M $61.50M
Capital Expenditures -$200.0K -$100.0K $881.0K
Free Cash Flow $68.50M $39.20M $60.62M
YoY Change 74.74% 12.0% 62.12%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021 dei Amendment Flag
AmendmentFlag
false
CY2021 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021 dei Entity Central Index Key
EntityCentralIndexKey
0001393052
CY2019 us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
us-gaap:AccountingStandardsUpdate201602Member
CY2020 us-gaap Gain Loss On Foreign Currency Fair Value Hedge Derivatives
GainLossOnForeignCurrencyFairValueHedgeDerivatives
0 USD
CY2019 us-gaap Gain Loss On Foreign Currency Fair Value Hedge Derivatives
GainLossOnForeignCurrencyFairValueHedgeDerivatives
0 USD
CY2020Q1 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
veev:OperatingAndFinanceLeaseLiabilityCurrent
CY2021Q1 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
veev:OperatingAndFinanceLeaseLiabilityCurrent
CY2021Q1 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
veev:OperatingAndFinanceLeaseLiabilityNoncurrent
CY2020Q1 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
veev:OperatingAndFinanceLeaseLiabilityNoncurrent
CY2021 dei Document Type
DocumentType
10-K
CY2021 dei Document Annual Report
DocumentAnnualReport
true
CY2021 dei Document Period End Date
DocumentPeriodEndDate
2021-01-31
CY2021 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--01-31
CY2021 dei City Area Code
CityAreaCode
925
CY2021 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2021 dei Document Transition Report
DocumentTransitionReport
false
CY2021 dei Entity File Number
EntityFileNumber
001-36121
CY2021 dei Entity Registrant Name
EntityRegistrantName
Veeva Systems Inc.
CY2021 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-8235463
CY2021 dei Entity Address Address Line1
EntityAddressAddressLine1
4280 Hacienda Drive
CY2021 dei Entity Address City Or Town
EntityAddressCityOrTown
Pleasanton
CY2021 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2021 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94588
CY2021 dei Local Phone Number
LocalPhoneNumber
452-6500
CY2021 dei Security12b Title
Security12bTitle
Class A Common Stock,par value $0.00001 per share
CY2021 dei Trading Symbol
TradingSymbol
VEEV
CY2021 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2021 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2021 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2021 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021 dei Entity Small Business
EntitySmallBusiness
false
CY2021 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2021 dei Entity Shell Company
EntityShellCompany
false
CY2020Q3 dei Entity Public Float
EntityPublicFloat
36000000000.0 USD
CY2021 dei Document Type
DocumentType
10-K
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
730504000 USD
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
476733000 USD
CY2021Q1 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
933122000 USD
CY2020Q1 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
610015000 USD
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
193000 USD
CY2020Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
617000 USD
CY2021Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
564387000 USD
CY2020Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
389690000 USD
CY2021Q1 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
47206000 USD
CY2020Q1 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
32817000 USD
CY2021Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
35607000 USD
CY2020Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
21869000 USD
CY2021Q1 us-gaap Assets Current
AssetsCurrent
2310826000 USD
CY2020Q1 us-gaap Assets Current
AssetsCurrent
1531124000 USD
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
53650000 USD
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
54752000 USD
CY2021Q1 us-gaap Deferred Costs
DeferredCosts
42072000 USD
CY2020Q1 us-gaap Deferred Costs
DeferredCosts
35585000 USD
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
56917000 USD
CY2020Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
49132000 USD
CY2021Q1 us-gaap Goodwill
Goodwill
436029000 USD
CY2020Q1 us-gaap Goodwill
Goodwill
438529000 USD
CY2021Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
114595000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
134601000 USD
CY2021Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
14100000 USD
CY2020Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
11870000 USD
CY2021Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
17878000 USD
CY2020Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
16184000 USD
CY2021Q1 us-gaap Assets
Assets
3046067000 USD
CY2020Q1 us-gaap Assets
Assets
2271777000 USD
CY2021Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
23253000 USD
CY2020Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
19420000 USD
CY2021Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
30410000 USD
CY2020Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
25619000 USD
CY2021Q1 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
30982000 USD
CY2020Q1 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
21620000 USD
CY2021Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
2590000 USD
CY2020Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
5613000 USD
CY2021Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
616992000 USD
CY2020Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
468887000 USD
CY2021Q1 veev Operating And Finance Lease Liability Current
OperatingAndFinanceLeaseLiabilityCurrent
11725000 USD
CY2020Q1 veev Operating And Finance Lease Liability Current
OperatingAndFinanceLeaseLiabilityCurrent
10013000 USD
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
715952000 USD
CY2020Q1 us-gaap Liabilities Current
LiabilitiesCurrent
551172000 USD
CY2021Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
1835000 USD
CY2020Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
2417000 USD
CY2021Q1 veev Operating And Finance Lease Liability Noncurrent
OperatingAndFinanceLeaseLiabilityNoncurrent
51393000 USD
CY2020Q1 veev Operating And Finance Lease Liability Noncurrent
OperatingAndFinanceLeaseLiabilityNoncurrent
44815000 USD
CY2021Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
10567000 USD
CY2020Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
7779000 USD
CY2021Q1 us-gaap Liabilities
Liabilities
779747000 USD
CY2020Q1 us-gaap Liabilities
Liabilities
606183000 USD
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
965670000 USD
CY2020Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
745475000 USD
CY2021Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
992000 USD
CY2020Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
460000 USD
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1299656000 USD
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
919658000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
2266320000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
1665594000 USD
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3046067000 USD
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2271777000 USD
CY2021 dei Document Type
DocumentType
10-K
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1465069000 USD
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1104081000 USD
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
862210000 USD
CY2021 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
408928000 USD
CY2020 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
303369000 USD
CY2019 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
245281000 USD
CY2021 us-gaap Gross Profit
GrossProfit
1056141000 USD
CY2020 us-gaap Gross Profit
GrossProfit
800712000 USD
CY2019 us-gaap Gross Profit
GrossProfit
616929000 USD
CY2020 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
27478000 USD
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
294220000 USD
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
209895000 USD
CY2019 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
158783000 USD
CY2021 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
235014000 USD
CY2020 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
190331000 USD
CY2019 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
148867000 USD
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
149113000 USD
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
114267000 USD
CY2019 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
86413000 USD
CY2021 us-gaap Operating Expenses
OperatingExpenses
678347000 USD
CY2020 us-gaap Operating Expenses
OperatingExpenses
514493000 USD
CY2019 us-gaap Operating Expenses
OperatingExpenses
394063000 USD
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
377794000 USD
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
286219000 USD
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
222866000 USD
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
16199000 USD
CY2019 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
15777000 USD
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
393993000 USD
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
313697000 USD
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
238643000 USD
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13995000 USD
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12579000 USD
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8811000 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
379998000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
301118000 USD
CY2019 us-gaap Net Income Loss
NetIncomeLoss
229832000 USD
CY2021 veev Net Income Loss Attributable To Common Stockholders Basic And Diluted
NetIncomeLossAttributableToCommonStockholdersBasicAndDiluted
379998000 USD
CY2020 veev Net Income Loss Attributable To Common Stockholders Basic And Diluted
NetIncomeLossAttributableToCommonStockholdersBasicAndDiluted
301118000 USD
CY2019 veev Net Income Loss Attributable To Common Stockholders Basic And Diluted
NetIncomeLossAttributableToCommonStockholdersBasicAndDiluted
229832000 USD
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.52
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.04
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.59
CY2021 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
985000 USD
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.36
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.90
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.47
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
150666000 shares
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
147796000 shares
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
144244000 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
160732000 shares
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
158296000 shares
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
156117000 shares
CY2020 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
2388000 USD
CY2019 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1409000 USD
CY2021 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-453000 USD
CY2020 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-2857000 USD
CY2019 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-2081000 USD
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
380530000 USD
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
300649000 USD
CY2019 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
229160000 USD
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
185001000 USD
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
115906000 USD
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
76425000 USD
CY2021 dei Document Type
DocumentType
10-K
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
906238000 USD
CY2019 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
25554000 USD
CY2019 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0 USD
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
76797000 USD
CY2019 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-672000 USD
CY2019 veev Net Income Loss Including Cumulative Effect Of Change On Equity Due To New Accounting Pronouncement Or Change In Accounting Principle
NetIncomeLossIncludingCumulativeEffectOfChangeOnEquityDueToNewAccountingPronouncementOrChangeInAccountingPrinciple
229832000 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
1237749000 USD
CY2020 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
10899000 USD
CY2020 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0 USD
CY2020 veev Adjustments To Additional Paid In Capital Share Based Compensation Replacement Award Value
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationReplacementAwardValue
657000 USD
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
116296000 USD
CY2020 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-468000 USD
CY2020 veev Net Income Loss Including Cumulative Effect Of Change On Equity Due To New Accounting Pronouncement Or Change In Accounting Principle
NetIncomeLossIncludingCumulativeEffectOfChangeOnEquityDueToNewAccountingPronouncementOrChangeInAccountingPrinciple
301118000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
1665594000 USD
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
34816000 USD
CY2021 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0 USD
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
185380000 USD
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
532000 USD
CY2021 veev Net Income Loss Including Cumulative Effect Of Change On Equity Due To New Accounting Pronouncement Or Change In Accounting Principle
NetIncomeLossIncludingCumulativeEffectOfChangeOnEquityDueToNewAccountingPronouncementOrChangeInAccountingPrinciple
379998000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
2266320000 USD
CY2021 dei Document Type
DocumentType
10-K
CY2021 us-gaap Profit Loss
ProfitLoss
379998000 USD
CY2020 us-gaap Profit Loss
ProfitLoss
301118000 USD
CY2019 us-gaap Profit Loss
ProfitLoss
229832000 USD
CY2021 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
29455000 USD
CY2020 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
19859000 USD
CY2019 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
14071000 USD
CY2021 veev Operating Lease Right Of Use Asset Amortization
OperatingLeaseRightOfUseAssetAmortization
10347000 USD
CY2020 veev Operating Lease Right Of Use Asset Amortization
OperatingLeaseRightOfUseAssetAmortization
7966000 USD
CY2019 veev Operating Lease Right Of Use Asset Amortization
OperatingLeaseRightOfUseAssetAmortization
0 USD
CY2021 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-3134000 USD
CY2020 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
3274000 USD
CY2019 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
2431000 USD
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
185001000 USD
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
115906000 USD
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
76425000 USD
CY2021 veev Amortization Of Deferred Costs Excluding Right Of Use Assets
AmortizationOfDeferredCostsExcludingRightOfUseAssets
20677000 USD
CY2020 veev Amortization Of Deferred Costs Excluding Right Of Use Assets
AmortizationOfDeferredCostsExcludingRightOfUseAssets
20521000 USD
CY2019 veev Amortization Of Deferred Costs Excluding Right Of Use Assets
AmortizationOfDeferredCostsExcludingRightOfUseAssets
18378000 USD
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1048000 USD
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-6663000 USD
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-8091000 USD
CY2021 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
365000 USD
CY2020 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
120000 USD
CY2019 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
177000 USD
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-307000 USD
CY2020 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
244000 USD
CY2019 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
198000 USD
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
174067000 USD
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
55531000 USD
CY2019 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
78995000 USD
CY2021 veev Increase Decrease In Unbilled Accounts Receivable
IncreaseDecreaseInUnbilledAccountsReceivable
14387000 USD
CY2020 veev Increase Decrease In Unbilled Accounts Receivable
IncreaseDecreaseInUnbilledAccountsReceivable
14555000 USD
CY2019 veev Increase Decrease In Unbilled Accounts Receivable
IncreaseDecreaseInUnbilledAccountsReceivable
4774000 USD
CY2021 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
27164000 USD
CY2020 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
25237000 USD
CY2019 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
18941000 USD
CY2021 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-3023000 USD
CY2020 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
1131000 USD
CY2019 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
637000 USD
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
12424000 USD
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2700000 USD
CY2019 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
10562000 USD
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
754000 USD
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2813000 USD
CY2019 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1822000 USD
CY2021 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
13889000 USD
CY2020 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-15230000 USD
CY2019 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
963000 USD
CY2021 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
147479000 USD
CY2020 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
97753000 USD
CY2019 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
89416000 USD
CY2021 veev Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
-9129000 USD
CY2020 veev Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
-7480000 USD
CY2019 veev Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
0 USD
CY2021 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
2426000 USD
CY2020 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
854000 USD
CY2019 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
3056000 USD
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
551246000 USD
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
437375000 USD
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
310827000 USD
CY2021 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
979292000 USD
CY2020 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
752518000 USD
CY2019 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
726379000 USD
CY2021 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
654341000 USD
CY2020 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
688091000 USD
CY2019 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
632329000 USD
CY2021 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
CY2020 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
448162000 USD
CY2019 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
CY2021 us-gaap Payments For Software
PaymentsForSoftware
8683000 USD
CY2020 us-gaap Payments For Software
PaymentsForSoftware
4321000 USD
CY2019 us-gaap Payments For Software
PaymentsForSoftware
9819000 USD
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-333634000 USD
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-516910000 USD
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-103869000 USD
CY2021 veev Finance Lease Proceeds Payments Net
FinanceLeaseProceedsPaymentsNet
-1039000 USD
CY2020 veev Finance Lease Proceeds Payments Net
FinanceLeaseProceedsPaymentsNet
-984000 USD
CY2019 veev Finance Lease Proceeds Payments Net
FinanceLeaseProceedsPaymentsNet
0 USD
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
34857000 USD
CY2020 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
10994000 USD
CY2019 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
25910000 USD
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
33818000 USD
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
10010000 USD
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
25910000 USD
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
484000 USD
CY2020 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-2856000 USD
CY2019 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-2077000 USD
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
251914000 USD
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-72381000 USD
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
230791000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
479797000 USD
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
552178000 USD
CY2018Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
321387000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
731711000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
479797000 USD
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
552178000 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
730504000 USD
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
476733000 USD
CY2019Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
550971000 USD
CY2021Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
1207000 USD
CY2020Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
3064000 USD
CY2019Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
1207000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
731711000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
479797000 USD
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
552178000 USD
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
18096000 USD
CY2020 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
14289000 USD
CY2019 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
19541000 USD
CY2021 veev Excess Tax Benefit From Employee Stock Plans
ExcessTaxBenefitFromEmployeeStockPlans
80661000 USD
CY2020 veev Excess Tax Benefit From Employee Stock Plans
ExcessTaxBenefitFromEmployeeStockPlans
50411000 USD
CY2019 veev Excess Tax Benefit From Employee Stock Plans
ExcessTaxBenefitFromEmployeeStockPlans
45830000 USD
CY2021 veev Increase Decrease In Capital Expenditures Incurred But Not Yet Paid
IncreaseDecreaseInCapitalExpendituresIncurredButNotYetPaid
3165000 USD
CY2020 veev Increase Decrease In Capital Expenditures Incurred But Not Yet Paid
IncreaseDecreaseInCapitalExpendituresIncurredButNotYetPaid
567000 USD
CY2019 veev Increase Decrease In Capital Expenditures Incurred But Not Yet Paid
IncreaseDecreaseInCapitalExpendituresIncurredButNotYetPaid
644000 USD
CY2021 dei Document Type
DocumentType
10-K
CY2021Q1 veev Number Of Regulated Industries
NumberOfRegulatedIndustries
3 industry
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with GAAP requires us to make estimates, judgments and assumptions that affect the consolidated financial statements and the notes thereto. These estimates are based on information available as of the date of the consolidated financial statements. On a regular basis, management evaluates these estimates and assumptions. Items subject to such estimates and assumptions include, but are not limited to:</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">the standalone selling price for each distinct performance obligation included in customer contracts with multiple performance obligations;</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">the determination of the period of benefit for amortization of deferred costs;</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">the fair value of assets acquired and liabilities assumed for business combinations; and</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">the fair value of our stock-based awards.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As future events cannot be determined with precision, actual results could differ significantly from those estimates.</span></div>
CY2021 dei Document Type
DocumentType
10-K
CY2021 veev Amortization Period Of Deferred Costs
AmortizationPeriodOfDeferredCosts
P3Y
CY2021 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Certain Risks and Concentrations of Credit Risk</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenues are derived from subscription services, professional services and other services delivered primarily to the life sciences industry. We operate in markets that are highly competitive and rapidly changing. Significant technological changes, shifting customer needs, the emergence of competitive products or services with new capabilities, and other factors could negatively impact our future operating results.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our financial instruments that potentially subject us to concentration of credit risk consist primarily of cash and cash equivalents, short-term investments and trade accounts receivable. Our cash equivalents and short-term investments are held by established financial institutions. We have established guidelines relative to credit ratings, </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">diversification and maturities that seek to maintain safety and liquidity. Deposits in these financial institutions may significantly exceed federally insured limits.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not require collateral from our customers and generally require payment within 30 days to 60 days of billing.</span></div>
CY2021 dei Document Type
DocumentType
10-K
CY2021 veev Maximum Period To Consider Highly Liquid Investments As Cash Equivalents
MaximumPeriodToConsiderHighlyLiquidInvestmentsAsCashEquivalents
P3M
CY2019 us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
1.29
CY2021 dei Document Type
DocumentType
10-K
CY2021 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2021 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 USD
CY2021 dei Document Type
DocumentType
10-K
CY2021 dei Document Type
DocumentType
10-K
CY2021Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
3879000 USD
CY2021Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
30000 USD
CY2021 dei Document Type
DocumentType
10-K
CY2021 us-gaap Guarantees Indemnifications And Warranties Policies
GuaranteesIndemnificationsAndWarrantiesPolicies
<div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Indemnification</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our contracts generally include provisions for indemnifying customers against liabilities if our solutions infringe a third party’s intellectual property rights, and we may also incur liabilities if we breach the security and/or confidentiality obligations in our contracts. To date, we have not incurred any material costs, and we have not accrued any liabilities in the accompanying consolidated financial statements as a result of these obligations.</span></div>
CY2021Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
929273000 USD
CY2021 dei Document Type
DocumentType
10-K
CY2020 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
1153497000 USD
CY2019 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
913081000 USD
CY2020 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
278215000 USD
CY2019 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
201382000 USD
CY2020 us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
1.88
CY2019 us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
1.40
CY2020 us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
1.76
CY2021Q1 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
933122000 USD
CY2020Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
607454000 USD
CY2020Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
2565000 USD
CY2020Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
4000 USD
CY2020Q1 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
610015000 USD
CY2021Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
428155000 USD
CY2020Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
247592000 USD
CY2020Q1 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
610015000 USD
CY2021 dei Document Type
DocumentType
10-K
CY2021Q1 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
933122000 USD
CY2021Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
504967000 USD
CY2020Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
362423000 USD
CY2021Q1 us-gaap Deferred Costs
DeferredCosts
42000000 USD
CY2020Q1 us-gaap Deferred Costs
DeferredCosts
36000000 USD
CY2021 us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
21000000 USD
CY2020 us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
21000000 USD
CY2019 us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
18000000 USD
CY2021 us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
0 USD
CY2019 us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
0 USD
CY2020 us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
0 USD
CY2021Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
83266000 USD
CY2020Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
80102000 USD
CY2021Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
29616000 USD
CY2020Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
25350000 USD
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
53650000 USD
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
54752000 USD
CY2021 us-gaap Depreciation
Depreciation
9000000 USD
CY2020 us-gaap Depreciation
Depreciation
9000000 USD
CY2019 us-gaap Depreciation
Depreciation
6000000 USD
CY2021Q1 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
171176000 USD
CY2021Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
56581000 USD
CY2021 dei Document Type
DocumentType
10-K
CY2021Q1 us-gaap Goodwill
Goodwill
436000000 USD
CY2020Q1 us-gaap Goodwill
Goodwill
439000000 USD
CY2021Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
114595000 USD
CY2020Q1 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
174670000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
40069000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
134601000 USD
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
20000000 USD
CY2020 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
10000000 USD
CY2019 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
7000000 USD
CY2021Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
18163000 USD
CY2021Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
18163000 USD
CY2021Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
18160000 USD
CY2021Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
17417000 USD
CY2021Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
13166000 USD
CY2021Q1 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
29526000 USD
CY2021Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
114595000 USD
CY2019Q1 us-gaap Goodwill
Goodwill
95804000 USD
CY2020Q1 us-gaap Goodwill
Goodwill
438529000 USD
CY2021Q1 us-gaap Goodwill
Goodwill
436029000 USD
CY2021 dei Document Type
DocumentType
10-K
CY2021Q1 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
7498000 USD
CY2020Q1 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
8951000 USD
CY2021Q1 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
4134000 USD
CY2020Q1 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
4329000 USD
CY2021Q1 us-gaap Accrued Vacation Current
AccruedVacationCurrent
4716000 USD
CY2020Q1 us-gaap Accrued Vacation Current
AccruedVacationCurrent
3921000 USD
CY2021Q1 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
10250000 USD
CY2020Q1 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
7353000 USD
CY2021Q1 us-gaap Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
3812000 USD
CY2020Q1 us-gaap Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
1065000 USD
CY2021Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
30410000 USD
CY2020Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
25619000 USD
CY2021Q1 veev Accrued Fees Current
AccruedFeesCurrent
6381000 USD
CY2020Q1 veev Accrued Fees Current
AccruedFeesCurrent
5787000 USD
CY2021Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
13598000 USD
CY2020Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
4914000 USD
CY2021Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1515000 USD
CY2020Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1338000 USD
CY2021Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
9488000 USD
CY2020Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
9581000 USD
CY2021Q1 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
30982000 USD
CY2020Q1 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
21620000 USD
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
15951000 USD
CY2021 dei Document Type
DocumentType
10-K
CY2021 dei Document Type
DocumentType
10-K
CY2021 us-gaap Gain Loss On Foreign Currency Fair Value Hedge Derivatives
GainLossOnForeignCurrencyFairValueHedgeDerivatives
-2000000 USD
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
378042000 USD
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
305339000 USD
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
222743000 USD
CY2019 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
5466000 USD
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
4763000 USD
CY2020 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
4695000 USD
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
8358000 USD
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
15900000 USD
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
393993000 USD
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
313697000 USD
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
238643000 USD
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
7108000 USD
CY2020 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
11143000 USD
CY2019 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
4089000 USD
CY2021 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
2825000 USD
CY2020 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
3404000 USD
CY2019 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
7438000 USD
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
14696000 USD
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
19242000 USD
CY2019 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
16993000 USD
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-816000 USD
CY2020 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-1063000 USD
CY2019 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-1910000 USD
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
681000 USD
CY2020 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-517000 USD
CY2019 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-619000 USD
CY2021 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-566000 USD
CY2020 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-5083000 USD
CY2019 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-5653000 USD
CY2021 veev Deferred Income Tax Expense Benefit1
DeferredIncomeTaxExpenseBenefit1
-701000 USD
CY2020 veev Deferred Income Tax Expense Benefit1
DeferredIncomeTaxExpenseBenefit1
-6663000 USD
CY2019 veev Deferred Income Tax Expense Benefit1
DeferredIncomeTaxExpenseBenefit1
-8182000 USD
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13995000 USD
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12579000 USD
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8811000 USD
CY2021 dei Document Type
DocumentType
10-K
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
82739000 USD
CY2020 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
65876000 USD
CY2019 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
50115000 USD
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
4401000 USD
CY2020 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
3035000 USD
CY2019 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
3139000 USD
CY2021 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
24617000 USD
CY2020 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
23468000 USD
CY2019 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
21415000 USD
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
-54488000 USD
CY2020 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
-34569000 USD
CY2019 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
-33332000 USD
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
10269000 USD
CY2020 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
7408000 USD
CY2019 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
6666000 USD
CY2021 us-gaap Income Tax Reconciliation Tax Contingencies Foreign
IncomeTaxReconciliationTaxContingenciesForeign
-941000 USD
CY2020 us-gaap Income Tax Reconciliation Tax Contingencies Foreign
IncomeTaxReconciliationTaxContingenciesForeign
470000 USD
CY2019 us-gaap Income Tax Reconciliation Tax Contingencies Foreign
IncomeTaxReconciliationTaxContingenciesForeign
3381000 USD
CY2021 veev Effective Income Tax Rate Reconciliation Deduction Foreign Derived Intangible Income
EffectiveIncomeTaxRateReconciliationDeductionForeignDerivedIntangibleIncome
5134000 USD
CY2020 veev Effective Income Tax Rate Reconciliation Deduction Foreign Derived Intangible Income
EffectiveIncomeTaxRateReconciliationDeductionForeignDerivedIntangibleIncome
4836000 USD
CY2019 veev Effective Income Tax Rate Reconciliation Deduction Foreign Derived Intangible Income
EffectiveIncomeTaxRateReconciliationDeductionForeignDerivedIntangibleIncome
2086000 USD
CY2021 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
1766000 USD
CY2020 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
-1337000 USD
CY2019 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
2343000 USD
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13995000 USD
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12579000 USD
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8811000 USD
CY2021Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
13494000 USD
CY2020Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
10355000 USD
CY2021Q1 us-gaap Deferred Tax Assets State Taxes
DeferredTaxAssetsStateTaxes
679000 USD
CY2020Q1 us-gaap Deferred Tax Assets State Taxes
DeferredTaxAssetsStateTaxes
931000 USD
CY2021Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
11486000 USD
CY2020Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
9861000 USD
CY2021Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
29318000 USD
CY2020Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
32916000 USD
CY2021Q1 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
29624000 USD
CY2020Q1 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
21458000 USD
CY2021Q1 veev Deferred Tax Assets Lease Liabilities
DeferredTaxAssetsLeaseLiabilities
15932000 USD
CY2020Q1 veev Deferred Tax Assets Lease Liabilities
DeferredTaxAssetsLeaseLiabilities
13808000 USD
CY2021Q1 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
298000 USD
CY2020Q1 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
217000 USD
CY2021Q1 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
100831000 USD
CY2020Q1 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
89546000 USD
CY2021Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
31318000 USD
CY2020Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
22694000 USD
CY2021Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
69513000 USD
CY2020Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
66852000 USD
CY2021Q1 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
141000 USD
CY2020Q1 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
650000 USD
CY2021Q1 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
30253000 USD
CY2020Q1 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
33518000 USD
CY2021Q1 us-gaap Deferred Tax Liabilities Deferred Expense Capitalized Software
DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware
893000 USD
CY2020Q1 us-gaap Deferred Tax Liabilities Deferred Expense Capitalized Software
DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware
974000 USD
CY2021Q1 veev Deferred Tax Liabilities Lease Right Of Use Assets
DeferredTaxLiabilitiesLeaseRightOfUseAssets
14438000 USD
CY2020Q1 veev Deferred Tax Liabilities Lease Right Of Use Assets
DeferredTaxLiabilitiesLeaseRightOfUseAssets
12717000 USD
CY2021Q1 us-gaap Deferred Tax Liabilities Deferred Expense
DeferredTaxLiabilitiesDeferredExpense
10588000 USD
CY2020Q1 us-gaap Deferred Tax Liabilities Deferred Expense
DeferredTaxLiabilitiesDeferredExpense
8922000 USD
CY2021Q1 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
935000 USD
CY2020Q1 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
619000 USD
CY2021Q1 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
57248000 USD
CY2020Q1 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
57400000 USD
CY2021Q1 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
12265000 USD
CY2020Q1 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
9452000 USD
CY2021Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
82000000 USD
CY2021Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
91000000 USD
CY2021Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
29000000 USD
CY2021 dei Document Type
DocumentType
10-K
CY2021 veev Percentage Of Likelihood Of Tax Benefit Being Realized Upon Effective Settlement
PercentageOfLikelihoodOfTaxBenefitBeingRealizedUponEffectiveSettlement
0.50
CY2021Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
19000000 USD
CY2021Q1 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
9000000 USD
CY2020Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
14515000 USD
CY2020 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
0 USD
CY2019 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
403000 USD
CY2019Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
12597000 USD
CY2018Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
11398000 USD
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
96000 USD
CY2020 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
796000 USD
CY2019 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
968000 USD
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
4126000 USD
CY2020 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
3420000 USD
CY2019 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
2697000 USD
CY2021 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
51000 USD
CY2020 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
128000 USD
CY2019 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
1754000 USD
CY2021 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
0 USD
CY2021Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
18628000 USD
CY2020Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
14515000 USD
CY2019Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
12597000 USD
CY2021 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
58000 USD
CY2020 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
2170000 USD
CY2019 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
309000 USD
CY2021 dei Document Type
DocumentType
10-K
CY2021 us-gaap Operating Lease Expense
OperatingLeaseExpense
13000000 USD
CY2020 us-gaap Operating Lease Expense
OperatingLeaseExpense
8000000 USD
CY2019 us-gaap Operating Lease Expense
OperatingLeaseExpense
6000000 USD
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
11401000 USD
CY2020 us-gaap Operating Lease Payments
OperatingLeasePayments
7657000 USD
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
12214000 USD
CY2020 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
23546000 USD
CY2021 veev Right Of Use Asset Obtained In Exchange For Operating Lease Liability From Business Combinations
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityFromBusinessCombinations
0 USD
CY2020 veev Right Of Use Asset Obtained In Exchange For Operating Lease Liability From Business Combinations
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityFromBusinessCombinations
14550000 USD
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
56917000 USD
CY2020Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
49132000 USD
CY2021Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
11347000 USD
CY2020Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
8960000 USD
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
40.64
CY2021Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
51393000 USD
CY2020Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
44453000 USD
CY2021Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
62740000 USD
CY2021Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
62740000 USD
CY2020Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
53413000 USD
CY2021Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y8M12D
CY2020Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y1M6D
CY2021Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.038
CY2020Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.043
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
12887000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
11780000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
10585000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
7809000 USD
CY2021Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
62740000 USD
CY2021Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
62740000 USD
CY2021 dei Document Type
DocumentType
10-K
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
6867000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
21576000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
71504000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
8764000 USD
CY2021Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
0 USD
CY2021 dei Document Type
DocumentType
10-K
CY2021 dei Document Type
DocumentType
10-K
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
13448026 shares
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y4M24D
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1427000000 USD
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1427362 shares
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
181.18
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1839723 shares
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
18.92
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
274376 shares
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
123.50
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
12761289 shares
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
57.48
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
2794000000 USD
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
6817037 shares
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
17.50
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P2Y10M24D
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
1765000000 USD
CY2021 dei Document Type
DocumentType
10-K
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
12761289 shares
CY2020 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
27478000 USD
CY2019 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
15777000 USD
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
57.48
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P5Y
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
2794000000 USD
CY2021Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
215000000 USD
CY2021Q1 us-gaap Share Price
SharePrice
276.44
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
376000000 USD
CY2021 dei Document Type
DocumentType
10-K
CY2021 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
2275000 USD
CY2020 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-708000 USD
CY2019 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-2103000 USD
CY2021 us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
-3082000 USD
CY2020 us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
3001000 USD
CY2019 us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
2492000 USD
CY2021 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
15859000 USD
CY2020 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
25185000 USD
CY2019 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
15388000 USD
CY2021 veev Other Income Miscellaneous
OtherIncomeMiscellaneous
1147000 USD
CY2020 veev Other Income Miscellaneous
OtherIncomeMiscellaneous
0 USD
CY2019 veev Other Income Miscellaneous
OtherIncomeMiscellaneous
0 USD
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
16199000 USD
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1045222 shares
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1461255 shares
CY2019 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3054322 shares
CY2021 dei Document Type
DocumentType
10-K
CY2021 dei Document Type
DocumentType
10-K
CY2021 dei Document Type
DocumentType
10-K
CY2021Q1 veev Number Of Product Areas
NumberOfProductAreas
2 industry
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1465069000 USD
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1104081000 USD
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
862210000 USD
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1465069000 USD
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1104081000 USD
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
862210000 USD
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
53650000 USD
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
54752000 USD
CY2021 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
6000000 USD
CY2020 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
4000000 USD
CY2019 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
3000000 USD
CY2021 dei Document Type
DocumentType
10-K
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
396761000 USD
CY2020Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
377519000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
353683000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
337106000 USD
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
311508000 USD
CY2019Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
280921000 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
266900000 USD
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
244752000 USD
CY2021Q1 us-gaap Gross Profit
GrossProfit
282914000 USD
CY2020Q4 us-gaap Gross Profit
GrossProfit
274522000 USD
CY2020Q3 us-gaap Gross Profit
GrossProfit
256479000 USD
CY2020Q2 us-gaap Gross Profit
GrossProfit
242226000 USD
CY2020Q1 us-gaap Gross Profit
GrossProfit
217189000 USD
CY2019Q4 us-gaap Gross Profit
GrossProfit
207592000 USD
CY2019Q3 us-gaap Gross Profit
GrossProfit
196682000 USD
CY2019Q2 us-gaap Gross Profit
GrossProfit
179249000 USD
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
98843000 USD
CY2020Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
101305000 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
90081000 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
87565000 USD
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
60394000 USD
CY2019Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
80800000 USD
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
73856000 USD
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
71169000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
102918000 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
96959000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
93551000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
86570000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
66182000 USD
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
82245000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
79242000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
73449000 USD
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.68
CY2020Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.64
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.62
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.58
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.44
CY2019Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.56
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.54
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.50
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.64
CY2020Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.60
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.58
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.54
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.42
CY2019Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.52
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.50
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.47
CY2021 dei Document Type
DocumentType
10-K

Files In Submission

Name View Source Status
0001393052-21-000015-index-headers.html Edgar Link pending
0001393052-21-000015-index.html Edgar Link pending
0001393052-21-000015.txt Edgar Link pending
0001393052-21-000015-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
veev-20210131.htm Edgar Link pending
veev-20210131.xsd Edgar Link pending
veev-20210131xex107.htm Edgar Link pending
veev-20210131xex231.htm Edgar Link pending
veev-20210131xexx103.htm Edgar Link pending
veev-20210131xexx211.htm Edgar Link pending
veev-20210131xexx311.htm Edgar Link pending
veev-20210131xexx312.htm Edgar Link pending
veev-20210131xexx321.htm Edgar Link pending
veev-20210131xexx322.htm Edgar Link pending
veev-20210131xexx42.htm Edgar Link pending
veev-20210131_cal.xml Edgar Link unprocessable
veev-20210131_def.xml Edgar Link unprocessable
veev-20210131_g1.jpg Edgar Link pending
veev-20210131_g2.jpg Edgar Link pending
veev-20210131_htm.xml Edgar Link completed
veev-20210131_lab.xml Edgar Link unprocessable
veev-20210131_pre.xml Edgar Link unprocessable